Literature DB >> 30033162

Generation of methylated violapyrones with improved anti-influenza A virus activity by heterologous expression of a type III PKS gene in a marine Streptomyces strain.

Lukuan Hou1, Shuyao Wang1, Huiming Huang1, Huayue Li2, Wei Wang3, Wenli Li4.   

Abstract

Heterologous expression of the type III polyketide synthase (PKS) gene vioA in marine-derived Streptomyces youssoufiensis OUC6819 led to production of six violapyrones (VLPs), including four novel compounds VLPs Q-T (1-4) and two known compounds VLPs B and I (5 and 6). The structures of 1-4 were elucidated by a combination of spectroscopic analyses, including HR-ESIMS and 1D and 2D NMR data, demonstrating that 1-4 are novel VLPs which are methylated at 4-OH with their corresponding non-methylated counterparts to be VLP A, 5 and 6 and VLP C, respectively. Anti-influenza A [H1N1 (A/Virginia/ATCC1/2009) and H3N2 (A/Aichi/2/1968)] virus activity of compounds 1-6 as well as VLPs A and C were then evaluated using ribavirin as a positive control (IC50 = 66.7 and 99.6 μM). The results revealed that these VLPs showed considerable anti-H1N1 and anti-H3N2 activities with IC50 values of 30.6-132.4 μM and 45.3-150.0 μM, respectively. Notably, all the methylated VLPs displayed better anti-virus activity than their non-methylated counterparts, among which compound 3 (VLP S) exhibited the best activities. Interestingly, methylation at 4-OH has negative effect on the anti-MRSA (methicillin-resistant Staphylococcus aureus) activity instead, with methylated VLPs displaying decreased (2) or abolished (3 and 4) activities in comparison with each of their non-methylated counterparts.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-MRSA; Anti-influenza A; Heterologous expression; Streptomyces; Violapyrones (VLPs)

Mesh:

Substances:

Year:  2018        PMID: 30033162     DOI: 10.1016/j.bmcl.2018.07.029

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

Review 1.  Recent progresses in marine microbial-derived antiviral natural products.

Authors:  Yun-Fei Teng; Li Xu; Mei-Yan Wei; Chang-Yun Wang; Yu-Cheng Gu; Chang-Lun Shao
Journal:  Arch Pharm Res       Date:  2020-11-21       Impact factor: 4.946

Review 2.  Antiviral potential of natural products from marine microbes.

Authors:  Mengqi Yi; Sixiao Lin; Bin Zhang; Haixiao Jin; Lijian Ding
Journal:  Eur J Med Chem       Date:  2020-08-31       Impact factor: 6.514

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.